Skip to content

Clinical trials

Terminated Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Terminated Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20093
20113
20144
20152
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
AIO-Studien-gGmbH1
Amgen1
AstraZeneca1
Auron Healthcare GmbH1
Broncus Medical Inc1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Eli Lilly and Company1
Hanmi Pharmaceutical Company Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms19
Carcinoma, Non-Small-Cell Lung13
Neoplasms4
Breast Neoplasms3
Adenocarcinoma of Lung2
Carcinoma2
Lung Diseases2
Neoplasms by Site2
Prostatic Neoplasms2
Respiratory Tract Diseases2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.